Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Newly discovered thrombin inhibitors patented by Merck

March 21, 2003

Novel platelet ADP receptor inhibitors in Millennium development pipeline

March 21, 2003

New alpha2beta1 integrin antagonists identified at Ajinomoto

March 18, 2003

Bayer researchers describe novel series of selective factor Xa inhibitors

March 18, 2003

Catalyst Pharmaceutical will seek licenses for NM-702

March 13, 2003

Merck presents new antithrombotic thrombin receptor antagonists

March 13, 2003

Lilly researchers claim piperidine-containing factor Xa inhibitors

March 13, 2003

New factor Xa inhibitors in early development at Bayer

March 10, 2003

Argatroban meets primary endpoints in ARGIS-I study

March 7, 2003

Priority review granted for Arixtra sNDA

March 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...